Epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Enterobacterales in Africa: A systematic review.

Abstract

OBJECTIVES:

Carbapenem-resistant Enterobacterales (CRE) commonly cause hospital-acquired infections and hospital outbreaks worldwide, with an alarming increase in Africa, necessitating review of regional CRE epidemiological trends.

METHODS:

A systematic review was conducted using PRISMA guidelines, searching PubMed, Scopus and Web of Science databases for studies describing CRE distribution, risk factors for CRE acquisition and clinical outcome of CRE infections in Africa.

RESULTS:

One-hundred and sixty-nine studies were included, with the majority from North Africa (92/169, 54.4%). Most studies (136/169; 80.4%) focused only on infection, with a total of 15666 CRE isolates (97.4% clinical infection, 2.6% colonisation). The leading bacterial species included Klebsiella (72.2%), Escherichia coli (13.5%), and Enterobacter (8.3%). The most frequently detected carbapenemases were NDM (43.1%) and OXA-48-like (42.9%). Sequence types were reported in 44 studies, with ST101 and ST147 most commonly reported in K. pneumoniae, and ST410, ST167 and ST38 in E. coli. Previous antibiotic use, prior hospitalisation, surgical procedures, indwelling devices, intensive care unit admission and prolonged hospital stay, were the most frequent factors associated with CRE infection/colonisation. Crude mortality for CRE infection was 37%.

CONCLUSION:

Although K. pneumoniae and E. coli remain the most frequent CRE in Africa, observed sequence types are not the commonly reported global 'high-risk' clones. The distribution of species and carbapenemases differs across African regions, while risk factors for CRE colonisation/infection, and patient outcomes are similar to those reported globally. There are limited data on CREs from parts of Africa, highlighting the need to strengthen epidemiologic surveillance programmes in the region.

• Authors: Moloto Kedišaletše, Dube Phumuzile, Dramowski Angela, Whitelaw Andrew, Newton-Foot Mae
• Journal: Journal of global antimicrobial resistance (J Glob Antimicrob Resist) Vol. 35 Pg. 297-306 (Dec 2023) ISSN: 2213-7173 [Electronic] Netherlands
• PMID: 37879456 (Publication Type: Systematic Review, Journal Article, Review)
• Copyright: Copyright © 2023. Published by Elsevier Ltd.

Chemical References

• Carbapenems

Topics

• Humans
• Carbapenems (pharmacology)
• Escherichia coli
• Enterobacteriaceae Infections (drug therapy, epidemiology, microbiology)
• Carbapenem-Resistant Enterobacteriaceae
• Klebsiella pneumoniae
• Risk Factors